We deliver solutions at the intersection of patient advocacy and life science innovation.

The world of clinical research is rapidly growing to be more patient-centric. With more than 20 years of industry experience, we operationalize your patient engagement efforts at every stage of the R&D process.

A few of the forward-thinking biopharmaceutical companies who built patient engagement initiatives with PAS

How we launch projects with our partners

At Patient Advocacy Strategies, our mission is to make your breakthrough research accessible to the patient communities you're working to serve. To do so, we collaborate closely with your internal stakeholders and your target patients and advocacy organizations. And in doing so, we craft patient-facing initiatives that translates your science into enthusiastic engagement from your target audiences.

01.

Introduce us to your work.

We want to listen to your progress, your wins, and your challenges. Our team consults with yours over a series of conversations to discern exactly where your patient engagements needs could be, and collaborate with your stakeholders to align key teams around a set of shared goals.

02.

Mapping your patient landscape.

As we consult with your teams, our own team members begin the crucial work of mapping the key organizations, advocates, and opinion leaders in your target indication. This mapping provides our teams a guide that informs and shapes our eventual patient engagement strategies.

03.

Gathering buy-in and launching initatives.

We craft our guidance for what mix of patient engagement initiatives would most benefit your team. In doing so, we work with you and your key stakeholders to ensure that all members of the team are bought into the strategy and that their own internal teams' needs are being heard and met.

04.

Iteration for today and tomorrow.

Research never stands still. Neither will we. Our strategies and our engagement with your team is ever-evolving. This means that our work will always be forward-looking, and that your team won't have to worry about being surprised by unexpected patient community needs or concerns.
Let's Work Together

We build solutions at the intersection of patient advocacy and the life sciences.

patient engagement timeline

Early engagement with patients can lead to a greater than 500x return on investment.

So, when should your team operationalize your patient engagement work?
The answer: As early as possible.

Patient insights to inform trial parameters, endpoints, meaningful patient experience improvements

Patient advisory sessions expose study logistical considerations. 

Patient co-created materials
+ contact list building 

Patient-ready versions
of research materials

Grassroots engagement
begins to develop trust

Patient participation in investor pitches

Dedicated Patients and Community
pages on corporate website

Clinical trial webpages for key patient demographics

Unbranded education via webpages and promotional campaigns

Patient co-developed educational materials

Social media
engagement and outreach

Patient advisory councils
to review patient materials

Individual engagement
with patient influencers

Social media summits

Patient-led FDA engagement

Proactive patient-led value assessment engagement (Icer) 

Patient voice-infused materials for
promotion and education

Patient voices at launch
to inspire employees

Co-hosted programs with PAGs
at approval to amplify label

Post-market social listening and followup data reporting

Communication of clinical data
to patient communities

Payer engagement and education


Grassroots initiatives
for public access policy reform 

Direct-to-consumer education and  production promotion

patient engagement timeline

Early engagement with patients can lead to a greater than 500x return on investment.

So, no matter where your team's research pipeline may be, it's never too early to engage your target patient communities.

PAS' long-standing advocacy relationships and experience in building engagement initiatives for teams at every phase of the R&D cycle can accelerate the scoping and implementation of your team's patient outreach strategies.

Click on the stage most relevant to your team's pipeline here to find some of the various ways we can help you engage with patients.
Get in touch
Patient insights to inform trial parameters, endpoints, meaningful patient experience improvements

Patient advisory sessions expose study logistical considerations.

Patient co-created materials
+ contact list building

Patient-ready versions
of research materials

Grassroots engagement
begins to develop trust

Patient participation in investor pitches

Dedicated Patients and Community
pages on corporate website
Clinical trial webpages for key patient demographics

Unbranded education via webpages and promotional campaigns

Patient co-developed educational materials

Social media
engagement and outreach

Patient advisory councils
to review patient materials

Individual engagement
with patient influencers

Social media summits


Patient insights to inform trial parameters, endpoints, meaningful patient experience improvements

Patient advisory sessions expose study logistical considerations.

Patient co-created materials
+ contact list building

Patient-ready versions
of research materials

Grassroots engagement
begins to develop trust

Patient participation in investor pitches

Dedicated Patients and Community
pages on corporate website
Post-market social listening and followup data reporting

Communication of clinical data
to patient communities

Payer engagement and education


Grassroots initiatives
for public access policy reform

Direct-to-consumer education and  production promotion

Patient Advocacy Strategies encompasses three major practices: Strategies, Studio, and Synthesis.

These wide-ranging in-house capabilities enable the Patient Advocacy Strategies team to fully scope, plan, create, and execute unique patient-engaging initiatives from concept to campaign completion.

From our latest white paper

What can $100,000 do for your commercial pipeline?

How can patient engagement accelerate commercialization timelines? What is the impact of avoiding a costly protocol amendment? And how can your team ensure your patient engagement tactics are built to generate these sorts of measurable results?

In our latest Synthesis report, we dive deep into research that demonstrates what kind of impact a $100,000 investment in early patient engagement activities could have on a team's clinical research pipeline and timelines to commercialization.
Read the Report

2.5 years

Measured acceleration of a pre-phase 2 product launch due to early patient engagement

$62 million

Increase in net present value of a commercialized drug due to clinical operations boost from early patient engagement

500x

Return on investment on a $100,000 budget allocated to early patient engagement

More Insights from the Intersection of Advocacy and Research

Synthesis is a regularly-updated set of industry reports designed for life sciences professionals who wish to bring the impact of patient advocacy into their organizations.
Read the Reports

Patient Advocacy Strategies encompasses three major practices: Strategies, Studio & Synthesis.

Between these in-house teams, the Patient Advocacy Strategies team can fully scope, plan, create, and execute unique patient-engaging initiatives from concept to campaign completion.

Best-in-class patient engagement

The foundation for strategy development begins at the convergence of business objectives and patient needs. Under PAS leadership, the patient voice is effectively integrated to enrich the value creation of the drug development process.
Learn More about strategies

Strategy Development

The foundation for strategy development begins at the convergence of business objectives and patient needs

Disease Landscape Analysis

Our vast network of patient and disease stakeholders enables us to map the most effective influencers with a health condition and therapeutic area

Patient Testimony

PAS brings over two decades of experience working with patient communities to optimize the narrative that amplifies what it is like to live with a health condition

Stakeholder Development and Coalition Building

PAS strategically aligns and engages diverse stakeholders with common objectives to galvanize collective action to achieve mutual goals

Non-Profit Advocacy Organization Leadership

PAS brings a wealth of experience leading patient advocacy organizations, charitable and philanthropic foundations to maximize resources to advance their purpose

Public Policy Advocacy

PAS builds alliances with disease leaders and influencers to construct policies that maximizes patient access to high-quality care to improve health outcomes

Score

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Creative Development Designed For Patient Engagement

The foundation for strategy development begins at the convergence of business objectives and patient needs. Under PAS leadership, the patient voice is effectively integrated to enrich the value creation of the drug development process.
Learn More about Studio

Creative Development

The foundation for strategy development begins at the convergence of business objectives and patient needs.

Brand Identity

Our vast network of patient and disease stakeholders enables us to map the most effective influencers with a health condition and therapeutic area

Web Development

PAS brings over two decades of experience working with patient communities to optimize the narrative that amplifies what it is like to live with a health condition

Content Creation

PAS strategically aligns and engages diverse stakeholders with common objectives to galvanize collective action to achieve mutual goals

Print Design

PAS brings a wealth of experience leading patient advocacy organizations, charitable and philanthropic foundations to maximize resources to advance their purpose

Data Visualizations

PAS builds alliances with disease leaders and influencers to construct policies that maximizes patient access to high-quality care to improve health outcomes

Score

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Best-in-class patient engagement

The foundation for strategy development begins at the convergence of business objectives and patient needs. Under PAS leadership, the patient voice is effectively integrated to enrich the value creation of the drug development process.
Learn More about strategies

Social Listening

The foundation for strategy development begins at the convergence of business objectives and patient needs.

Digital Landscape Analysis

Our vast network of patient and disease stakeholders enables us to map the most effective influencers with a health condition and therapeutic area

Competitive Landscape Analysis

PAS brings over two decades of experience working with patient communities to optimize the narrative that amplifies what it is like to live with a health condition

Bespoke Data Reporting

PAS strategically aligns and engages diverse stakeholders with common objectives to galvanize collective action to achieve mutual goals

Patient Landscape Surveys

PAS brings a wealth of experience leading patient advocacy organizations, charitable and philanthropic foundations to maximize resources to advance their purpose

Score

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Our Past Work

From mobilizing patient communities to influence public policy to developing first-of-kind non-profits for rare, unrepresented patient groups and beyond, Patient Advocacy Strategies has developed and executed innovative, impactful work on behalf of leading life science clients for years.
See All Case Studies

Measuring Patient Landscape in Niched Women’s Health Area

Create a coalition model to galvanize the largely fragmented pre-partum and post-partum mental health community.
Read more ⟶

Global Launch of a New Rare Blood Cancer Therapeutic

Create a coalition model to galvanize the largely fragmented pre-partum and post-partum mental health community.
Read more ⟶

Partner Testimonials

Patient Advocacy Strategies has uniquely established themselves as pioneers in this important space and will add great value to any company and any patient community, and through this dialogue help accelerate medical innovation and the development of novel treatments.

Robert Coughlin
Former President & CEO
MassBio

I had the privilege of hiring and working with Mike at MedImmune in 2009, on behalf of the most fragile premature infants at risk for Respiratory Syncytial Virus (RSV), the number one cause of re-hospitalization for all infants in our nation.

Mike’s passion, networking and relationship management skills earned him strong credibility and leadership among a variety of patient and professional stakeholders, societies, and healthcare policy organizations.

Mike sees the “big picture,” and knows how to work backwards to execute strategic plans that make tremendous change.  A rare talent indeed, Mike inspires the best in others, always having his compass set on delivering superior results for both clients and the patients they serve.

Carolyn TenEyck, RN
Sr. Director, Advocacy & Government Affairs
Prolacta Bioscience

Mike Walsh is the ultimate patient advocate.

Based on my experience working with him during his time at Genentech, I can honestly say I have never met anyone who was more focused and driven to help patients who suffered with lung fibrosis. His innovative ideas are part of the reason patients with lung fibrosis are having more positive outcomes.

Mary Salvatore MD, MBA
Associate Professor, Radiology
Columbia University Irving Medical Center

wAIHA Warriors would not be the resource it is today for patients with warm Autoimmune Hemolytic Anemia without the expertise of Mike, Kelly, and Terri of Patient Advocacy Strategies.

Experiencing a rare disease has unique obstacles. Even far more discouraging than a challenging path to diagnosis, fewer specialists who agree on the best course of treatment, and an uncertain future of recurrences, is the lack of public awareness, resulting in fewer educational resources and a non-existent community of support.

By including patients, medical experts, and clinical researchers in their strategic vision, PAS created a new landscape of learning about wAIHA. With the development of the wAIHA website and an extensive social media presence, Patient Advocacy Strategies has elevated wAIHA Warriors as the leading resource for educational information, clinical trials, and mental health assistance materials as patients navigate this rare disease.

Karen Jones
Patient advisory board member
wAIHA Warriors

Patient Advocacy Synthesis

Access the latest patient advocacy and industry insights, as synthesized by our team.

How Early Patient Engagement Leads to a greater than 500x rOI

Read our detailed breakdown ⟶

New FDA Guidance: Patient Engagement

Read our detailed breakdown ⟶

New FDA Guidance: Patient Engagement

Read our detailed breakdown ⟶

New FDA Guidance:
Patient Engagement

What the new FDA paper means for your team, and how you can best leverage the newest guidance. A breakdown of the details here.
Read our detailed breakdown ⟶

New FDA Guidance:
Patient Engagement

What the new FDA paper means for your team, and how you can best leverage the newest guidance. A breakdown of the details here.
Read our detailed breakdown ⟶

New FDA Guidance:
Patient Engagement

What the new FDA paper means for your team, and how you can best leverage the newest guidance. A breakdown of the details here.
Read our detailed breakdown ⟶

Access All Patient Advocacy Strategies Insights

PA Scores

This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.